PN5, an antimicrobial peptide from pine needles, killed multidrug-resistant Salmonella Typhimurium through membrane disruption and immune modulation, significantly improving survival in a mouse infection model.
Dual-function antimicrobialPN5 both directly kills MDR Salmonella via membrane disruption and boosts host immune clearance via NF-κB/MAPK modulation
What the researchers found
PN5 demonstrated dual-function activity: direct bactericidal membrane disruption against MDR S. Typhimurium plus immune modulation via NF-κB and MAPK pathways. It eliminated intracellular bacteria in macrophages, inhibited biofilm formation, and significantly improved survival in a murine infection model.
Why it matters
Multidrug-resistant Salmonella is a growing public health threat with limited treatment options. A natural peptide that both kills resistant bacteria directly and helps the immune system clear infection represents a fundamentally different approach than conventional antibiotics.
The numbers in context
PN5 was stable across diverse pH and temperature conditions. Inhibited biofilm formation. Eliminated intracellular S. Typhimurium in RAW 264.7 macrophages. Modulated NF-kB and MAPK signaling. Improved survival in murine infection model.
How the study worked
In vitro antibacterial assays (MIC, membrane disruption, biofilm inhibition, cytotoxicity), intracellular killing assays in RAW 264.7 macrophages, signaling pathway analysis (NF-κB, MAPK), and in vivo murine S. Typhimurium infection model.
Who was studied
Multidrug-resistant Salmonella Typhimurium in vitro and in mouse infection model
What this study cannot tell us
Derived from a plant source; scalability and cost of production need evaluation. Only tested against S. Typhimurium; activity against other MDR pathogens is unknown. Mouse model results require validation in larger animals and eventually humans. Pharmacokinetic properties not characterized.
How to read the evidence
Comprehensive preclinical study with in vitro mechanism of action, intracellular killing demonstration, and in vivo survival benefit. Strong proof of concept but limited to one pathogen species and animal models.
When this study was published
Published in 2025; represents current antimicrobial peptide discovery research.
The bigger picture
As antibiotic resistance continues to rise, antimicrobial peptides from natural sources offer alternative strategies. PN5's dual mechanism—directly killing bacteria while modulating host immunity—addresses a key limitation of traditional antibiotics, which only target the pathogen without supporting the immune response.
Questions still open
- Is PN5 effective against other multidrug-resistant bacterial species beyond Salmonella?
- Can PN5 be produced at scale for clinical development, and what are the manufacturing challenges?
- Would PN5 work synergistically with existing antibiotics to overcome resistance?
Common questions
How does PN5 kill drug-resistant bacteria?
Why is a peptide from pine needles being studied as a medicine?
Read the original research
Peptide PN5 from Pinus densiflora Confers in Vivo Protection Against Multidrug-Resistant Salmonella Typhimurium Through Membrane Disruption.
ACS omega, 10(50), 61322-61338
Citation
Park, Jonggwan; Kang, Da Dam; Kim, Hyeongsun; Oh, Jun Hee; Park, Yoonkyung. (2025). Peptide PN5 from Pinus densiflora Confers in Vivo Protection Against Multidrug-Resistant Salmonella Typhimurium Through Membrane Disruption.. ACS omega, 10(50), 61322-61338. https://doi.org/10.1021/acsomega.5c06012